{"title":"Neurofibromatosis type 1 with comorbid optic pathway glioma does not confer additional cognitive sequelae.","authors":"Rachel K Peterson, Rowena Ng","doi":"10.1093/arclin/acag059","DOIUrl":"https://doi.org/10.1093/arclin/acag059","url":null,"abstract":"<p><strong>Objective: </strong>Children with neurofibromatosis type 1 (NF1) are at risk for cognitive impairments. Optic pathway gliomas (OPGs) commonly occur in children with NF1, though whether OPG exacerbates cognitive vulnerabilities beyond the NF1 genotype remains unclear. This study compared cognition among children with NF1 and OPG (NF1 + OPG), children with NF1 without OPG (NF1-only), and children with central nervous system (CNS) tumors of the visual system without NF1 (CNS-V), to evaluate whether OPG confers additional cognitive risk beyond NF1.</p><p><strong>Method: </strong>This retrospective clinical cohort study included 98 pediatric patients referred for a clinical neuropsychological evaluation: 69 NF1-only, 21 NF1 + OPG, and 8 CNS-V tumor. Intellectual functioning, verbal reasoning, visuospatial reasoning, working memory, and processing speed were examined. Group differences were analyzed using one-way analyses of variance; chi-square tests assessed impairment rates.</p><p><strong>Results: </strong>Children with NF1 with and without OPG did not differ significantly across cognitive domains. Both NF1 groups (NF1-only and NF1 + OPG) demonstrated weaker verbal and visuospatial reasoning abilities compared to the CNS-V group. In contrast, children with CNS-V tumors performed within the average range across domains with significantly stronger intellectual performance than both NF1 groups.</p><p><strong>Conclusions: </strong>OPG does not appear to exacerbate cognitive vulnerability in children with NF1. Cognitive weaknesses in NF1 likely reflect the underlying genotype rather than added tumor burden. Comparatively, children with non-NF1 visual system tumors demonstrated average performance. These findings underscore the importance of routine neuropsychological monitoring in children with NF1 regardless of tumor status and highlight the need for prospective, adequately powered studies to further disentangle genotype- and tumor-related effects.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148709425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juan A Serrano-Salcedo, Antonio E Puente, Yazdel Guzmán-Echevarría, Mairim Vega-Carrero
{"title":"Subjective cognitive complaints and emotional symptoms after COVID-19: preliminary data in a sample of Puerto Rican adults.","authors":"Juan A Serrano-Salcedo, Antonio E Puente, Yazdel Guzmán-Echevarría, Mairim Vega-Carrero","doi":"10.1093/arclin/acag060","DOIUrl":"10.1093/arclin/acag060","url":null,"abstract":"<p><strong>Objective: </strong>This exploratory study examined relationships between predisposing factors (age, pre-morbid medical conditions, educational attainment), COVID-19 disease severity indicators (hospitalization status, symptom burden, symptom duration), and self-reported cognitive complaints and emotional symptoms in Puerto Rican adults with prior COVID-19.</p><p><strong>Method: </strong>Fifty-nine Puerto Rican adults (71.2% female; M age = 39.27 years, SD = 12.21) with a confirmed history of COVID-19 completed an investigator-developed sociodemographic questionnaire, the Neurobehavioral Symptom Inventory (NSI), and the Neuro-QoL v2.0 Cognitive Function-Short Form Spanish via an online platform. Non-parametric analyses included Spearman correlations, Mann-Whitney U tests, and Kruskal-Wallis tests with effect sizes. A sensitivity power analysis estimated the smallest detectable effects.</p><p><strong>Results: </strong>Symptom burden was the strongest correlate of self-reported cognitive and emotional symptoms, correlating positively with NSI Total (rho = 0.651, p < .001) and NSI Affective (rho = 0.637, p < .001) scores, and negatively with Neuro-QoL (rho = -0.329, p = .011). Pre-morbid conditions were associated with worse NSI Total (rho = 0.298, p = .022) and NSI Cognitive (rho = 0.344, p = .008). Age and education showed no significant associations. Cognitive complaints were strongly associated with emotional symptoms, holding across instruments and after adjusting for symptom burden. Hospitalization comparisons showed small-to-medium but nonsignificant effects, inconclusive given the small hospitalized subgroup.</p><p><strong>Conclusions: </strong>In this Puerto Rican sample, COVID-19 symptom burden and pre-morbid health status were the primary correlates of cognitive difficulties, which were closely intertwined with emotional symptoms. These exploratory findings offer preliminary empirical evidence to inform future research in Puerto Rico.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148709429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria Pleshkevich, Robiann Broomfield, Sydney Burton, Gabriela Castro, Alyssa G Gill, Matthew Jerram, Setari Parsa
{"title":"Attention deficit/hyperactivity disorder diagnosis in adulthood: Prevalence and predictive utility of neuropsychological scales.","authors":"Maria Pleshkevich, Robiann Broomfield, Sydney Burton, Gabriela Castro, Alyssa G Gill, Matthew Jerram, Setari Parsa","doi":"10.1093/arclin/acag057","DOIUrl":"https://doi.org/10.1093/arclin/acag057","url":null,"abstract":"<p><strong>Objective: </strong>This cross-sectional study investigated the prevalence of adult Attention Deficit/Hyperactivity Disorder (ADHD) evaluations in an outpatient neuropsychology clinic and the sensitivity and specificity of neuropsychological assessments in differentiating ADHD with comorbid psychiatric conditions from psychiatric-related cognitive deficits.</p><p><strong>Method: </strong>Logistic regression analyses were run on neuropsychological testing results extracted from medical records to evaluate each test's ability to predict ADHD diagnosis. Receiver Operating Characteristic curves were plotted, and an Area Under the Curve (AUC) >0.7 was considered acceptable.</p><p><strong>Results: </strong>Sixty-seven of 252 reviewed charts were included (n = 30 with ADHD, n = 37 without ADHD). Overall, 54% of individuals presenting to the clinic were referred for ADHD, and 58% of those diagnosed with ADHD had a comorbid psychiatric disorder. No cognitive testing was predictive of ADHD diagnosis (AUC range: 0.503-0.636). The Generalized Anxiety Disorder-7 was the strongest predictive scale of ADHD (AUC = 0.800; χ2(28) = 8.216, p = .004, Nagelkerke R2 = 0.333). Adults who endorsed higher levels of anxiety were 28% more likely to be diagnosed with ADHD (OR = 1.28, 95%CI [0.05, 0.45]). Subtests of ADHD scales performed worse, but still within the adequate range (AUC range: 0.703-0.751). Sample demographics were notable for over-representation of women (n = 46, 69%), and they skewed White (n = 43, 64%) and highly educated (M years of education = 15.79, SD = 1.94), which may limit generalizability.</p><p><strong>Conclusions: </strong>Cognitive testing profiles and screeners of current inattention and hyperactivity were indiscriminate between individuals with ADHD and comorbid psychiatric conditions versus psychiatric conditions alone. Current anxiety was the strongest predictor of adult ADHD diagnosis.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148650539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correction to: NeBa - Neglect battery: updated norms, new scores, and guidelines of a neuropsychological battery for the assessment of unilateral spatial neglect and associated disorders.","authors":"","doi":"10.1093/arclin/acag061","DOIUrl":"10.1093/arclin/acag061","url":null,"abstract":"","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13435224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148671788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Salgado-Blanco, Alberto Blanco-Campal, Unai Diaz-Orueta
{"title":"Cognitive profiles and predictors of cancer-related cognitive impairment in breast cancer survivors: integrating self-reported, neuropsychological, and process-based measures.","authors":"Cristina Salgado-Blanco, Alberto Blanco-Campal, Unai Diaz-Orueta","doi":"10.1093/arclin/acag062","DOIUrl":"10.1093/arclin/acag062","url":null,"abstract":"<p><strong>Objective: </strong>Characterizing cancer-related cognitive impairment (CRCI) remains challenging due to limitations in the sensitivity of neuropsychological tests and diagnostic criteria. This study aimed to (a) classify breast cancer survivors in CRCI groups using self-reported and neuropsychological categories; (b) explore whether CRCI is related to specific cognitive domains; (c) analyze if comorbid symptoms predict CRCI group membership; (d) study the correspondence between Montreal Cognitive Assessment (MoCA) and neuropsychological CRCI; and (e) explore cognitive profiles of CRCI groups considering Boston Process Approach (BPA) indices.</p><p><strong>Method: </strong>This cross-sectional study included 82 breast cancer survivors undergoing treatment and presenting mild depressive symptoms. Self-reported CRCI was assessed using the PROMIS-CF 8a, neuropsychological CRCI was defined following recommended criteria. Participants were classified into four independent CRCI groups: (a) non-CRCI; (b) subjective CRCI; (c) objective CRCI; (d) combined CRCI. Logistic regression models examined predictors, χ2 tests assessed MoCA correspondence, and group differences in BPA indices were studied through ANOVA.</p><p><strong>Results: </strong>Participants' mean age was 47.76 years, 71.95% exhibited self-reported CRCI and 48.78% neuropsychological CRCI. Anxiety predicted subjective and combined CRCI, while lower self-efficacy predicted combined CRCI. MoCA showed limited sensitivity and specificity for neuropsychological CRCI. The combined CRCI group exhibited poorer quality of life and lower performance on processing speed and verbal fluency tasks.</p><p><strong>Conclusions: </strong>CRCI assessment should include self-reported and neuropsychological measures. MoCA should not replace comprehensive neuropsychological assessment, while BPA may provide complementary meaningful information to characterize CRCI profiles. CRCI interventions should target executive functioning, anxiety, and self-efficacy. Longitudinal studies with control groups are required.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13524091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148852284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Demographically adjusted norms for a French-Quebec version of the face-name associative recognition test.","authors":"Joël Macoir, Mariane Landry, Carol Hudon","doi":"10.1093/arclin/acag053","DOIUrl":"10.1093/arclin/acag053","url":null,"abstract":"<p><strong>Objective: </strong>The Face-Name Associative Recognition Test (FNART) is a recognition-based measure of associative episodic memory designed to reduce retrieval demands while preserving sensitivity to hippocampal-dependent binding processes. The absence of normative data currently limits its clinical use. This study aimed to establish normative data for a Quebec French version (FNART-Q).</p><p><strong>Method: </strong>FNART-Q performance was examined in a large sample of cognitively healthy French-speaking Quebec adults, and percentile-based normative data were developed accounting for demographic influences.</p><p><strong>Results: </strong>A demographically stratified normative framework was developed using an overlapping stratification approach, and percentile ranks were derived to support clinical interpretation of individual scores.</p><p><strong>Conclusions: </strong>The FNART-Q provides clinically interpretable normative data, supporting its use as a demographically adjusted measure of associative episodic memory.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13426906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148650544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hannah M Lovato, Aya Haneda, Lauren Kenney, Kara Eversole, Matthew Calamia, Erin Sullivan-Baca, Rachael L Ellison
{"title":"Linking with Liaisons program evaluation: A Women in Neuropsychology of the Society for Clinical Neuropsychology (APA division 40) initiative to assist clinical psychology graduate applicants.","authors":"Hannah M Lovato, Aya Haneda, Lauren Kenney, Kara Eversole, Matthew Calamia, Erin Sullivan-Baca, Rachael L Ellison","doi":"10.1093/arclin/acag058","DOIUrl":"https://doi.org/10.1093/arclin/acag058","url":null,"abstract":"<p><strong>Objective: </strong>Admission to doctoral programs that provide clinical neuropsychology training is highly competitive. The Women in Neuropsychology committee (WIN: Society for Clinical Neuropsychology [SCN], American Psychological Association [APA] Division 40), in collaboration with New2Neuropsychology (N2N), created the Linking with Liaisons (LwL) initiative, the first neuropsychology-focused graduate application cycle initiative. LwL aimed to foster the advancement of underrepresented, minoritized, and repeat applicants through the 2024 doctoral graduate school application cycle in the USA and Canada.</p><p><strong>Method: </strong>Applications were matched with neuropsychology liaisons who reviewed application materials and conducted mock interviews. Additionally, applicants received informational sessions on the application process and interviewing. We present descriptive and qualitative survey data collected from 23 applicants and 17 liaisons.</p><p><strong>Results: </strong>Overall, the LwL initiative was rated very highly by both applicants and liaisons for communication, making applicants feel prepared, and offering a unique opportunity.</p><p><strong>Conclusion: </strong>Linking with Liaisons successfully engaged the targeted applicant pool, and findings support the feasibility and participant satisfaction with this initiative's format. To date, the success of programs such as the LwL initiative reinforces the importance of developing similar programs to strengthen recruitment and retention of individuals from underrepresented and minoritized groups in the field of clinical neuropsychology.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148687580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Forensic neuropsychology in criminal contexts: foundations, incremental validity, and applications to criminal responsibility evaluations.","authors":"Vera A Klinoff, Anthony J Giuliano","doi":"10.1093/arclin/acag056","DOIUrl":"10.1093/arclin/acag056","url":null,"abstract":"<p><p>The subspecialty of forensic neuropsychology has expanded considerably over the past two decades, along with increasing involvement of neuropsychological assessment in criminal forensic evaluations. Despite this growth, the role of neuropsychology in criminal responsibility (CR) evaluations remains underexamined. This paper (a) outlines the foundational importance of specialized knowledge in forensic neuropsychology as a basis for subspecialty development; (b) examines the potential incremental validity of neuropsychological data in CR evaluations; (c) analyzes the application of neuropsychological findings to key components of CR legal standards; (d) extends this analysis to broader exculpatory doctrines; and (e) frames these discussions in ways that inform multiple forensic stakeholders, including neuropsychologists engaged in forensic practice, forensic psychologists consulting with neuropsychologists, and trainees pursuing integrated training across forensic psychology and neuropsychology.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 6","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148805090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Robert D Shura, Mark J Stern, Jacob L Varela, Emily H Fannick, Will H Canu
{"title":"Conners Continuous Performance Test-3 performance in a sample of veterans assessed for attention-deficit/hyperactivity disorder: evidence of questionable diagnostic utility.","authors":"Robert D Shura, Mark J Stern, Jacob L Varela, Emily H Fannick, Will H Canu","doi":"10.1093/arclin/acag036","DOIUrl":"10.1093/arclin/acag036","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to examine the usefulness of the Conners Continuous Performance Test-3 (CPT-3) in a veteran sample evaluated for attention-deficit/hyperactivity disorder (ADHD).</p><p><strong>Method: </strong>The study used retrospective data from an outpatient ADHD assessment clinic at a Veterans Affairs Health Care System; patients completed a psychological assessment for diagnostic clarity of ADHD. After excluding those with missing or invalid data, deferred or other/unspecified ADHD diagnosis, severe neurological issues, and stimulant use the day of the exam, the final sample was 241: 144 met criteria for ADHD, 61 met criteria for another psychiatric diagnosis, and 36 were categorized as \"clinical\" controls. Diagnostic accuracy and non-parametric tests were used to examine the CPT-3 Clinical Likelihood Estimate (CLE) and nine primary performance scores with respect to ADHD diagnosis.</p><p><strong>Results: </strong>The CLE was not a good indicator of ADHD diagnosis, with an unacceptable AUC of 0.607 predicting ADHD status and 48.6% of those with ADHD identified as having a minimal likelihood of attention deficits. All nine primary CPT-3 scores were worse in those with ADHD than without, but differences were not clinically significant (d = 0.10-0.24). After controlling for psychiatric comorbidity, there were no differences across the ADHD and clinical control groups. Additionally, inattentive and combined presentations did not significantly differ in performance across all nine scores.</p><p><strong>Conclusions: </strong>The CPT-3 does not appear to be useful as a diagnostic tool when evaluating veterans for ADHD. There was no distinct ADHD subtype profile of score abnormalities.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148153171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anxiety in multiple sclerosis: an exploratory cross-sectional study of psychological, social, clinical, and neuroimaging factors.","authors":"Furkan Bahadır Alptekin, Didem Savaşçı, Betül Karaaslan, Özge Aşık, Ebrar Torlak","doi":"10.1093/arclin/acag050","DOIUrl":"10.1093/arclin/acag050","url":null,"abstract":"<p><strong>Objective: </strong>Anxiety is a common but often overlooked psychiatric comorbidity in multiple sclerosis (MS), significantly affecting quality of life. This cross-sectional study examined anxiety in MS patients using a biopsychosocial framework, aiming to identify differences from healthy controls and determine predictive factors.</p><p><strong>Methods: </strong>We compared 101 MS patients with 136 healthy controls using numeric rating scales for pain and fatigue, Hospital Anxiety and Depression Scale (HADS), Brief Resilience Scale, Acceptance and Action Questionnaire-II (AAQ-II), and multidimensional scale of perceived social support. Clinical data included Expanded Disability Status Scale (EDSS) scores and MRI measurements. Analyses included t-tests, Pearson correlations, and hierarchical regression.</p><p><strong>Results: </strong>Patients with MS had significantly higher HADS-Anxiety scores (M = 8.71, SD = 4.35) than healthy controls (M = 7.53, SD = 3.58; p = .023), with 30.7% meeting the clinical threshold for anxiety. Hierarchical regression analysis identified psychological inflexibility (β = 0.318, p < .001), depression (β = 0.264, p = .007), and female sex (β = 0.395, p = .032) as significant predictors of anxiety in patients with MS, explaining 48% of the total variance. Importantly, neurological disability, structural brain measures, clinical symptoms, and social support were not significant predictors of anxiety. However, EDSS scores were significantly associated with AAQ-II scores (r = 0.309, p = .002).</p><p><strong>Conclusions: </strong>Anxiety in MS is primarily influenced by psychological factors, particularly psychological inflexibility and comorbid depression, rather than biological variables. Findings support acceptance and commitment therapy-based interventions and routine psychiatric screening.</p>","PeriodicalId":520564,"journal":{"name":"Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists","volume":"41 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148400315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}